Tumor cell stemness in gastrointestinal cancer: regulation and targeted therapy

被引:0
|
作者
Yang, Kangqi [1 ]
Yi, Tuo [2 ]
机构
[1] Fudan Univ, Sch Basic Med Sci, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China
关键词
gastrointestinal tumor; cancer stem cell; tumor heterogeneity; tumor microenvironment; epithelial-to-mesenchymal transition; cancer-associated fibroblast; EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; GASTRIC-CANCER; PANCREATIC-CANCER; TGF-BETA; INITIATING CELLS; GROWTH-FACTOR; SELF-RENEWAL; HEPATOCELLULAR-CARCINOMA; T-CELLS;
D O I
10.3389/fmolb.2023.1297611
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cancer stem cells are a rare group of self-renewable cancer cells capable of the initiation, progression, metastasis and recurrence of tumors, and also a key contributor to the therapeutic resistance. Thus, understanding the molecular mechanism of tumor stemness regulation, especially in the gastrointestinal (GI) cancers, is of great importance for targeting CSC and designing novel therapeutic strategies. This review aims to elucidate current advancements in the understanding of CSC regulation, including CSC biomarkers, signaling pathways, and non-coding RNAs. We will also provide a comprehensive view on how the tumor microenvironment (TME) display an overall tumor-promoting effect, including the recruitment and impact of cancer-associated fibroblasts (CAFs), the establishment of an immunosuppressive milieu, and the induction of angiogenesis and hypoxia. Lastly, this review consolidates mainstream novel therapeutic interventions targeting CSC stemness regulation.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Cancer stem cells: Targeted differentiation therapy and preservation of stemness.
    Sell, Stewart
    TUMOR BIOLOGY, 2006, 27
  • [23] Imatinib and gastrointestinal stromal tumor (GIST):: a selective targeted therapy
    Fernández, A
    Aparicio, J
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (10) : 723 - 729
  • [24] Future of targeted therapy for gastrointestinal cancer:Claudin 18.2
    Qian Niu
    Jiamin Liu
    Xiaoxiao Luo
    Beibei Su
    Xianglin Yuan
    OncologyandTranslationalMedicine, 2021, 7 (03) : 102 - 107
  • [25] Regulation of tumor cell glycometabolism and tumor therapy
    Liu, Ge
    Song, Guanbin
    Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering, 2019, 36 (04): : 691 - 695
  • [26] Hot Topic: Molecular Targeted Therapy of Gastrointestinal Cancer
    Wiedmann, Marcus W.
    CURRENT CANCER DRUG TARGETS, 2011, 11 (06) : 670 - 680
  • [27] Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness
    Hass, Ralf
    von der Ohe, Juliane
    Ungefroren, Hendrik
    CANCERS, 2020, 12 (12) : 1 - 20
  • [28] Nanomedicine for cancer targeted therapy with autophagy regulation
    He, Ketai
    Chen, Mingkun
    Liu, Jiao
    Du, Shufang
    Ren, Changyu
    Zhang, Jifa
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [29] Endoglin for tumor imaging and targeted cancer therapy
    Paauwe, Madelon
    ten Dijke, Peter
    Hawinkels, Lukas J. A. C.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (04) : 421 - 435
  • [30] Tumor-targeted nanoparticles for cancer therapy
    Kang, HyungGyoo
    Upton, Bryon
    Nagy, Jon
    Triche, Timothy
    CANCER RESEARCH, 2024, 84 (06)